Zimmer Orthopedics Unit Of BMS To Become Separate Entity By Fourth Quarter
This article was originally published in The Gray Sheet
Executive Summary
Bristol-Myers Squibb's decision to spin off its Zimmer subsidiary as a separately traded public entity, instead of selling the unit outright, likely reflects the recently revived sales growth of the orthopedic operation.